Revance Therapeutics shares owned by Centaurus Financial
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Centaurus Financial
from 13F filings
Historical chart of Centaurus Financial investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Centaurus Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Centaurus Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $155k | 18k | 8.80 |
| 2023-09-30 | $281k | 25k | 11.46 |
| 2023-06-30 | $437k | 17k | 25.28 |
| 2023-03-31 | $512k | 16k | 32.24 |
| 2022-12-31 | $280k | 15k | 18.43 |
| 2022-09-30 | $443k | 16k | 27.00 |
| 2022-06-30 | $280k | 20k | 13.83 |
| 2022-03-31 | $403k | 21k | 19.48 |
| 2021-12-31 | $341k | 21k | 16.33 |
| 2021-09-30 | $1.4M | 51k | 27.86 |
| 2021-06-30 | $1.5M | 50k | 29.65 |
| 2021-03-31 | $1.4M | 51k | 27.96 |
| 2020-12-31 | $1.5M | 54k | 28.34 |
| 2020-09-30 | $1.5M | 61k | 25.13 |